Predicting Outcome in Adult Patients With Congenital Heart Disease: A Systematic Review and Meta-Analysis on the Predictive Value of NT-proBNP and High-Sensitive Troponin T

QR Code

Predicting Outcome in Adult Patients With Congenital Heart Disease: A Systematic Review and Meta-Analysis on the Predictive Value of NT-proBNP and High-Sensitive Troponin T

Conclusion: In conclusion, this meta-analysis shows the prognostic value of both NT-proBNP and hs-TnT in adults with congenital heart disease. Each of these markers offered a distinct but complementary clinical insight. Although methodological differences of the included studies limit direct compari...

Full description

Saved in:

Bibliographic Details
Main Authors:	Sara Rashki Ghalenoo, Zohreh Mahmoodi
Format:	Article
Language:	English
Published:	Wiley 2025-01-01
Series:	International Journal of Vascular Medicine
Online Access:	http://dx.doi.org/10.1155/ijvm/1210312
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Utility of cardiac biomarkers (NT-proBNP and Hs-troponin-T) in predicting mortality, cardiovascular and renal outcomes in patients with chronic kidney disease
by: Senthil Kandaswamy
Published: (2025-07-01)

GALECTIN-3 AND NT-proBNP AS BIOMARKERS OF HEART FAILURE DECOMPENSATION
by: Yu. V. Dubolazova, et al.
Published: (2017-02-01)

Navigating the Challenges of NT-proBNP Result Disclosure in Clinical Research
by: Denise A. Kent, et al.

Assessment of the Myocardial Stress Biomarker NT-proBNP in Real Clinical Practice
by: I. A. Kozlov, et al.
Published: (2023-02-01)

Lower NT‐proBNP plasma concentrations in Pacific peoples with heart failure
by: Andree G. Pearson, et al.
Published: (2025-08-01)

Serum NT-ProBNP/Chloride Ratio Predicts Adverse Cardiovascular Outcomes in Patients with Acute Heart Failure
by: Victor José Leal-Alcántara, et al.
Published: (2025-06-01)

The prognostic value of the NT-proBNP biomarkers and Fas ligand in assessing the risk of cardiotoxicity of anthracycline chemotherapy
by: A. T. Teplyakov, et al.
Published: (2019-03-01)

Changes in NT-proBNP levels in patients with sinus tachycardia after COVID-19
by: V. I. Podzolkov, et al.
Published: (2023-01-01)

Prognostic significance of the biomarker NT-proBNP in the surgical treatment of aortic stenosis (pilot study)
by: I. A. Kozlov, et al.
Published: (2023-06-01)

Potential of NT-proBNP and sST2 rapid tests in patients with acute myocardial infarction
by: V. V. Ryabov, et al.
Published: (2023-07-01)

SIGNIFICANCE OF STIMULATING GROWTH FACTOR ST2 AND NT-proBNP IN ASSESSMENT OF POSTINFARCTION REMODELING OF THE HEART
by: Yu. A. Dyleva, et al.
Published: (2015-12-01)

Macrophages in epicardial adipose tissue and serum NT-proBNP in patients with stable coronary artery disease
by: I. V. Kologrivova, et al.
Published: (2022-04-01)

Prognostic and diagnostic significance of the cardiac biomarker NT-proBNP in the perioperative period of vascular surgery procedures
by: I. A. Kozlov, et al.
Published: (2023-10-01)

Increased B-type Natriuretic Peptide (NT-proBNP) Level as a Risk Factor in Cardiosurgical Patients
by: I. A. Kozlov, et al.
Published: (2010-02-01)

Increased NT-proBNP levels and cardiac ventricular function during aortic valve replacement (pilot study)
by: I. A. Kozlov, et al.
Published: (2023-07-01)

Diagnostic Efficacy of Combined N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) and Cardiac Troponin I (cTnI) Testing in Myocardial Injury of Children with Mycoplasma Pneumoniae Pneumonia
by: Yang M, et al.
Published: (2025-06-01)

Prognostic value of the inferior vena cava diameter, lung ultrasound, and the NT-proBNP level in patients with acute decompensated heart failure and obesity
by: Zh. D. Kobalava, et al.
Published: (2023-04-01)

The Significance of the Cardiac Peptide NT-proBNP in the Assessment of Risk for Myocardial Revascularization in Patients with Decreased Left Ventricular Ejection Fraction
by: V. V. Moroz, et al.
Published: (2010-04-01)

Exploring heart failure prevalence and dimensions: A comprehensive NT‐proBNP study in high‐risk primary care patients
by: Ahmet Celik, et al.
Published: (2025-08-01)

Prognostic significance of NT-proBNP and sST2 in patients with heart failure with preserved and mildly reduced ejection fraction
by: V. I. Podzolkov, et al.
Published: (2023-10-01)

Clinical Features and the NT-proBNP Marker in Patients with Chronic Heart Failure in the Setting of Atrial Fibrillation and Chronic Obstructive Pulmonary Disease
by: Т. A. Dzyurich, et al.
Published: (2019-09-01)

The level of the cardiac peptide NT-proBNP and indices of the scale of assessment of clinical status in chronic heart failure patients with ischemic cardiomyopathy
by: E. I. Myasoedova, et al.
Published: (2016-06-01)

EVALUATION OF CORRELATION BETWEEN NT-proBNP BIOMARKER WITH RATES OF HEMODYNAMICS AND PULMONARY EXTRAVASCULAR WATER IN PATIENTS WITH ACUTE RESPIRATORY DISTRESS SYNDROME
by: S. A. Komarov, et al.
Published: (2017-11-01)

Elevated central blood pressure, NT-proBNP and hs-cTnI in women with maternal complications of hypertensive disorders of pregnancy
by: Xolani B. Mbongozi, et al.
Published: (2025-12-01)

Changes of NT-proBNP and sST2 levels for predicting isolated episodes of ventricular tachyarrhythmias and electrical storm in patients with systolic heart failure and various implanted devices
by: A. Zh. Gasparyan, et al.
Published: (2020-12-01)

Associations of NT-proBNP and hepcidin levels with clinical and laboratory parameters in patients with heart failure with various severity of left ventricular systolic dysfunction
by: V. I. Podzolkov, et al.
Published: (2020-09-01)

Association between NT‐proBNP changes and clinical outcomes in paediatric patients with heart failure: Insights from PANORAMA‐HF and PARADIGM‐HF
by: Robert Shaddy, et al.
Published: (2025-08-01)

Usefulness of Combining NT-proBNP Level and Right Atrial Diameter for Simple and Early Noninvasive Detection of Pulmonary Hypertension Among Adult Patients with Atrial Septal Defect
by: Anggoro Budi Hartopo, et al.
Published: (2023-01-01)

Assessment of the Level of NT-proBNP in Patients with Arterial Hypertension Aged 80 Years and Older, Depending on the Presence of Heart Failure and Senile Asthenia Syndrome
by: V A. Safronenko, et al.
Published: (2024-10-01)

Prognostic significance of NT-proBNP and sST2 biomarkers in patients with post-myocardial infarction heart failure after a coronavirus infection
by: N. M. Kalashnikova, et al.
Published: (2023-07-01)

Time course of changes in the level of N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients with rheumatoid arthritis during therapy with an interleukin-6 receptor inhibitor
by: E. V. Gerasimova, et al.
Published: (2019-11-01)

Minimizing unnecessary proBNP blood tests: an evaluation of a pop-up form implementation in general practice
by: Morvarid Sophia Esmaeilzadeh, et al.
Published: (2025-01-01)

THE LEVEL OF CARDIAC PEPTIDE NT-PROBNP INCREASES DURING PRE-ECLAMPSIA OF PREGNANT WOMEN
by: Н. Русой, et al.
Published: (2025-04-01)

High-sensitivity cardiac troponins: circadian rhythms
by: A. M. Chaulin, et al.
Published: (2021-02-01)

Biomarkers in predicting cardiovascular risk: new prospects of troponin I
by: A. V. Kontsevaya, et al.
Published: (2020-07-01)

ВКЛАД ОЦЕНКИ БИОМАРКЕРОВ SST2 И NT-PROBNP В ВОЗМОЖНОСТЬ ПРОГНОЗИРОВАНИЯ СЕРДЕЧНОЙ ДЕКОМПЕНСАЦИИ И ЖИЗНЕУГРОЖАЮЩИХ ЖЕЛУДОЧКОВЫХ ТАХИАРИТМИЙ
Published: (2019-06-01)

High-sensitivity cardiac troponins: detection and central analytical characteristics
by: A. M. Chaulin, et al.
Published: (2021-03-01)

Statins and highly sensitive cardiac troponins: cardiotoxicity or cross-reactivity?
by: A. M. Chaulin, et al.
Published: (2023-05-01)

Clinical Diagnostic Value of Stromelysin-2 and Highly Sensitive-Cardiac Troponin I in the Severity of Coronary Artery Obstruction
by: Amal A. Hammoodi, et al.
Published: (2025-07-01)

ESTIMATION OF HIGHLY SENSITIVE TROPONIN TESTS IN THE DIAGNOSIS OF ACUTE CORONARY SYNDROME
by: L. V. Kremneva, et al.
Published: (2016-05-01)